Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmcenter VILAR is a Russian pharmaceutical company specializing in the development and manufacture of original phytopharmaceuticals derived from medicinal plants. Established as the production arm of the All-Russian Scientific Research Institute of Medicinal and Aromatic Plants (VILAR), the company bridges the gap between botanical research and clinical application. Its product portfolio includes unique antiviral, antimicrobial, and hepatoprotective agents such as Alpizarin, Hiporamin, and Sanguiritrin. The company maintains its own manufacturing facilities in Moscow, capable of processing raw plant materials into standardized extracts and finished dosage forms. Pharmcenter VILAR's products are primarily marketed within Russia and the CIS region, focusing on infectious diseases and gastroenterology. The organization continues to leverage the extensive scientific heritage of the VILAR Institute to introduce natural therapeutic solutions to the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmcenter VILAR.